<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2014-11-05 17:47:19Organic chemistry Chemotherapy-induced nausea and vomiting 5-HT3 antagonist Aprepitant Dolasetron Metoclopramide NK1 receptor antagonist Ondansetron Granisetron Chemistry Medicine Antiemetics |
Add to Reading List |
Antiemetics/Antivertigo Agents | P11444 - ASCO2014 MEC and HECDocID: 1a4Ek - View Document |
 | P11444 - ASCO2014 MEC and HECDocID: 19OCx - View Document |
 | Astellas Receives Approval for a Supplemental New Drug Application for Irribow®/Irribow® OD, a Treatment of Diarrhea-predominant Irritable Bowel Syndrome, in Japan Tokyo, May 26, Astellas Pharma Inc. (“AstellaDocID: 19AF1 - View Document |
 | P11444 - ASCO2014 MEC and HECDocID: 199Dl - View Document |
 | P11444 - ASCO2014 MEC and HECDocID: 1987o - View Document |